Clinical trial · Interventional
mychoiceTM Implementation With Medical Oncology Patients
mychoiceTM Implementation in a Real World Clinical Environment - Delivery and Effectiveness
NCT06222242CI-TRIAL-00073243unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a pragmatic, non-randomized mixed-methods evaluation study designed to evaluate the feasibility and acceptability of delivering the mychoiceTM tool to new Medical Oncology patients as well as to more deeply explore its value to patients in their discussion with their provider about clinical trials as a treatment option over the course of their oncology treatment (Effectiveness).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| mychoiceTM | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- mychoiceTM intervention
- description
- Single arm study - all participants receive mychoiceTM
- interventionNames
- Behavioral: mychoiceTM
Primary outcomes (3)
- measure
- Feasibility to disseminate the mychoice tool to patients
- timeFrame
- 24 months
- description
- Assess the feasibility of disseminating the mychoiceTM preparatory tool to all Medical Oncology patients and the acceptability (measured by recommendation to other patients. Patient feasibility will focus on the proportion of patients who receive the mychoiceTM tool and open the web-based intervention (goal 50%).
- measure
- Acceptability
- timeFrame
- 24
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 18 years of age or over Able to speak and read English Medical Oncology patients who have had their initial visit Have a cell phone number and/or an email in the electronic medical record Exclusion Criteria Doesn't not speak or read English Patients who do not have a cancer diagnosis
References
Publications (0)
Data not yet available
No reference posted for this study.